Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$37.23M-83.5%$225.61M+49.5%$150.86M+49.4%$101.01M+16.5%$86.69M-31.6%
$15.16M+47.4%$10.29M-22.2%$13.22M+27.2%$10.4M-2.3%$10.64M-7.7%
$65.19M-34.9%$100.17M+25.6%$79.74M+8.0%$73.81M+1.8%$72.51M-1.8%
$106.12M-34.6%$162.32M+24.7%$130.14M+14.6%$113.58M+0.1%$113.44M-2.6%
$25.77M-48.4%$49.92M+37.7%$36.25M+31.2%$27.63M+16.5%$23.72M-23.6%
-$68.89M-209%$63.29M+205%$20.73M+265%-$12.58M+53.0%-$26.75M
-185.1%-213pp28.1%+14.3pp13.7%+26.2pp-12.5%+18.4pp-30.9%
-$380K-61.0%-$236K+43.1%-$415K+38.0%-$669K+30.4%-$961K
$418K+203%$138K-68.1%$433K-41.6%$742K-22.9%$963K
-$68.47M-208%$63.43M+200%$21.16M+279%-$11.83M+54.1%-$25.78M
-$15.32M-178%$19.73M+4,947%-$407K+83.3%-$2.44M+64.8%-$6.94M
-$53.16M-222%$43.7M+103%$21.57M+330%-$9.39M+50.2%-$18.84M-346%
-142.8%-162pp19.4%+5.1pp14.3%+23.6pp-9.3%+12.4pp-21.7%-27.8pp
-$0.44-263%$0.27+145%$0.11+210%-$0.10+41.2%-$0.17
-$64.72M-196%$67.36M+172%$24.76M+380%-$8.84M+62.1%-$23.3M
-173.8%-204pp29.9%+13.4pp16.4%+25.2pp-8.8%+18.1pp-26.9%
-$68.89M-209%$63.29M+205%$20.73M+265%-$12.58M+53.0%-$26.75M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Organogenesis Holdings Inc.'s revenue?
Organogenesis Holdings Inc. (ORGO) generated $514.7M in revenue over the trailing twelve months, up 12.2% year over year.
Is Organogenesis Holdings Inc. profitable?
Organogenesis Holdings Inc. reported $2.7M in net income over the trailing twelve months, a 0.5% net margin.
What are Organogenesis Holdings Inc.'s profit margins?
Gross margin is 75.9% and operating margin is 0.5%, with a 0.5% net margin.
What is Organogenesis Holdings Inc.'s earnings per share?
Organogenesis Holdings Inc.'s diluted EPS over the trailing twelve months is $-0.16.
Where does Organogenesis Holdings Inc.'s income statement data come from?
Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.